Cargando…

CHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival

BACKGROUND: Our recent studies suggested that the chromodomain helicase DNA binding protein 1-like (CHD1L) gene plays an oncogenic role in human hepatocellular carcinoma. However, the status of CHD1L protein expression in ovarian cancer and its clinical/prognostic significance are obscure. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Wei-Peng, Zhou, Juan, Cai, Mu-Yan, Xiao, Xiang-Shen, Liao, Yi-Ji, Kung, Hsiang-Fu, Guan, Xin-Yuan, Xie, Dan, Yang, Guo-Fen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551745/ https://www.ncbi.nlm.nih.gov/pubmed/23020525 http://dx.doi.org/10.1186/1471-2407-12-437

Ejemplares similares

Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival
por: He, Li-Ru, et al.
Publicado: (2015)

Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma
por: Liu, Ze-Han, et al.
Publicado: (2017)

Decreased Expression of Beclin 1 Correlates Closely with Bcl-xL Expression and Poor Prognosis of Ovarian Carcinoma
por: Lin, Huan-Xin, et al.
Publicado: (2013)

Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8
por: Marie, Corentine, et al.
Publicado: (2018)

CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma
por: Li, Shimiao, et al.
Publicado: (2019)

CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma
por: Li, Shimiao, et al.
Publicado: (2019)

Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer
por: Wu, Jiayi, et al.
Publicado: (2014)

CHD1L: a novel oncogene
por: Cheng, Wen, et al.
Publicado: (2013)

CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2
por: He, Wei-Peng, et al.
Publicado: (2020)

Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort
por: Tian, Chong, et al.
Publicado: (2016)

Transgenic CHD1L Expression in Mouse Induces Spontaneous Tumors
por: Chen, Muhan, et al.
Publicado: (2009)

Identification of CHD1L as an Important Regulator for Spermatogonial Stem Cell Survival and Self-Renewal
por: Liu, Shan-Shan, et al.
Publicado: (2016)

Corrigendum: Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort
por: Tian, Chong, et al.
Publicado: (2017)

Oral health status of CHD and non-CHD adults of Lahore, Pakistan
por: Bokhari, Syed Akhtar Hussain, et al.
Publicado: (2011)

CHD1L contributes to cisplatin resistance by upregulating the ABCB1–NF-κB axis in human non-small-cell lung cancer
por: Li, Yang, et al.
Publicado: (2019)

Progress in CHD Prevention
por: Lewis, Barry
Publicado: (1983)

CHD1 and CHD2 are positive regulators of HIV-1 gene expression
por: Rodgers, Melissa J, et al.
Publicado: (2014)

The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities
por: Manning, Benjamin J., et al.
Publicado: (2017)

A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers
por: Soltan, Mohamed A., et al.
Publicado: (2023)

The chromatin remodeling factor Chd1l is required in the preimplantation embryo
por: Snider, Alyssa C., et al.
Publicado: (2012)

Diversity roles of CHD1L in normal cell function and tumorigenesis
por: Xiong, Xifeng, et al.
Publicado: (2021)

Screening biomarkers for predicting the efficacy of immunotherapy in patients with PD-L1 overexpression
por: Zhu, Xiaodan, et al.
Publicado: (2023)

Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma
por: Xu, Lei, et al.
Publicado: (2022)

CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents
por: Oyama, Yoshiko, et al.
Publicado: (2021)

Photosensitivity and CHD2 Variants
por: Sosa, Rebecca García, et al.
Publicado: (2015)

Differential Expression and Sex Chromosome Association of CHD3/4 and CHD5 during Spermatogenesis
por: Bergs, Judith W., et al.
Publicado: (2014)

Expression of Hcy and blood lipid levels in serum of CHD patients and analysis of risk factors for CHD
por: Liu, Weijing, et al.
Publicado: (2019)

Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development
por: de Castro, Rodrigo O., et al.
Publicado: (2022)

CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3
por: Zhang, Xiaofeng, et al.
Publicado: (2021)

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality
por: Hoffmeister, Helen, et al.
Publicado: (2017)

Common CHD8 Genomic Targets Contrast With Model-Specific Transcriptional Impacts of CHD8 Haploinsufficiency
por: Wade, A. Ayanna, et al.
Publicado: (2019)

HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer
por: Wang, Yixuan, et al.
Publicado: (2017)

The high expression of CHD1L and its clinical significance in human solid tumors: A meta-analysis
por: Zhang, Long, et al.
Publicado: (2021)

The effects of CPET-guided cardiac rehabilitation on exercise tolerance in older persons with CHD after PCI
por: Shen, Tao, et al.
Publicado: (2023)

CHD2-Related CNS Pathologies
por: Wilson, Marc-Michel, et al.
Publicado: (2021)

CHD5 inhibits metastasis of neuroblastoma
por: Laut, Astrid K., et al.
Publicado: (2021)

Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
por: Liu, Jian-Ye, et al.
Publicado: (2013)

Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma
por: Xie, Cheng-Rong, et al.
Publicado: (2015)

Structural basis of ALC1/CHD1L autoinhibition and the mechanism of activation by the nucleosome
por: Wang, Li, et al.
Publicado: (2021)

A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer
por: Wang, Kai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_etc25b0skohe5mbgc3kqouggsl